Especially given the current share price and the low capital requirement needed in order to grow. If the shares were priced more appropriately (higher) it would make a lot less sense.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
